Aptevo Therapeutics Inc. (APVO) Stock Forecast & Price Target
Price as of Nov 17, 2026 close · Analyst estimates retrieved Nov 17, 2026 · Source: Financial Modeling Prep (analyst estimates) (methodology)
Revenue and earnings estimates published by analysts covering Aptevo Therapeutics Inc. (APVO), and the range of their price targets. Everything on this page is a forecast made by other people — DeltaScreener does not produce estimates or targets of its own.
For Aptevo Therapeutics Inc., the average estimate for 2030 earnings per share is $10.09; 2 analysts contribute to these figures. These are forecasts published by analysts, not results.
Revenue forecast (USD)
The spread between low and high is how far analysts disagree, which is usually a better guide than the average alone.
Earnings per share forecast
Aptevo Therapeutics Inc. (APVO) forecast — frequently asked questions
What are analysts forecasting for Aptevo Therapeutics Inc.'s earnings?
The average analyst estimate for Aptevo Therapeutics Inc. (APVO) earnings per share in 2030 is 10.09, with individual estimates between 10.09 and 10.09.
How much revenue is Aptevo Therapeutics Inc. expected to make?
Analysts forecast Aptevo Therapeutics Inc. (APVO) revenue of $66.57M in 2030, based on 1 published estimates.
How many analysts cover APVO?
2 analysts contribute estimates for Aptevo Therapeutics Inc. (APVO). Thin coverage makes an average less reliable.
Analyst forecasts for other Biotechnology stocks
Popular Stocks
Related stock screens
Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.